CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 25 of 110 entries

View as:

Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis

Phase: N/A Priority: Normal

NCT ID: NCT04397809 Org: User:

Start: 09/10/14 End: 08/31/21 Due: 08/31/22

Pneumococcal Post-Vaccination Titers

Phase: N/A Priority: Normal

NCT ID: NCT02726347 Org: User:

Start: 04/30/16 End: 04/30/18 Due: 04/30/19

Sub-Sensitivity to Long-Acting Bronchodilators (LABA)

Phase: N/A Priority: Normal

NCT ID: NCT01117116 Org: User:

Start: 03/31/10 End: 09/30/13 Due: 09/30/14

Lung Clearance Index to Identify Scleroderma Patients at Risk for ILD

Phase: N/A Priority: Normal

NCT ID: NCT04535245 Org: User:

Start: 01/04/21 End: 01/15/26 Due: 01/15/27

PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis

Phase: N/A Priority: Normal

NCT ID: NCT02419989 Org: User:

Start: 01/31/14 End: 03/31/25 Due: 03/31/26

COPDGene/Lung Cancer Center Database

Phase: N/A Priority: Normal

NCT ID: NCT02445183 Org: User:

Start: 12/31/13 End: 09/22/20 Due: 09/22/21

Effects of Sildenafil on CFTR-dependent Ion Transport Activity

Phase: N/A Priority: Normal

NCT ID: NCT01132482 Org: User:

Start: 10/31/15 End: 05/31/17 Due: 05/31/18

Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea

Phase: N/A Priority: Normal

NCT ID: NCT03109210 Org: User:

Start: 04/15/17 End: 06/30/26 Due: 06/30/27

Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis

Phase: N/A Priority: Normal

NCT ID: NCT03145922 Org: User:

Start: 01/31/16 End: 01/31/26 Due: 01/31/27

Phase II Study of Digitoxin to Treat Cystic Fibrosis

Phase: N/A Priority: Normal

NCT ID: NCT00782288 Org: User:

Start: 08/31/10 End: 08/31/16 Due: 08/31/17

Utility of Lung Clearance Index Score As a Noninvasive Marker of Small Airways Disease

Phase: N/A Priority: Normal

NCT ID: NCT03241420 Org: User:

Start: 04/24/17 End: 12/31/25 Due: 12/31/26

Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma

Phase: N/A Priority: Normal

NCT ID: NCT01589198 Org: User:

Start: 01/31/12 End: 06/30/16 Due: 06/30/17

The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy

Phase: N/A Priority: Normal

NCT ID: NCT01950533 Org: User:

Start: 09/30/13 End: 03/29/17 Due: 03/29/18

Changing School Start Times: Impact on Student, Family, Teacher, and Community Health

Phase: N/A Priority: Normal

NCT ID: NCT03964181 Org: User:

Start: 04/11/17 End: 07/31/21 Due: 07/31/22

Dog Hair Extract Study

Phase: N/A Priority: Normal

NCT ID: NCT01343420 Org: User:

Start: 11/30/10 End: 10/31/11 Due: 10/31/12

Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis

Phase: N/A Priority: Normal

NCT ID: NCT04024423 Org: User:

Start: 07/01/19 End: 07/01/23 Due: 07/01/24

The Role of JAK2 in Alveolar Macrophages (AM's) in Chronic Beryllium Disease (CBD)

Phase: N/A Priority: Normal

NCT ID: NCT02596347 Org: User:

Start: 04/30/15 End: 12/06/19 Due: 12/06/20

Deployment-Related Lung Disease Research Database and Biorepository

Phase: N/A Priority: Normal

NCT ID: NCT03035097 Org: User:

Start: 02/28/13 End: 12/31/30 Due: 12/31/31

Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma

Phase: N/A Priority: Normal

NCT ID: NCT02753764 Org: User:

Start: 01/31/17 End: 02/25/19 Due: 02/25/20

Viral-Related Neutrophil Response and Condition Severity in People With ARDS

Phase: N/A Priority: Normal

NCT ID: NCT00548795 Org: User:

Start: 08/31/07 End: 07/31/12 Due: 07/31/13

Telecommunication Enhanced Asthma Management

Phase: N/A Priority: Normal

NCT ID: NCT00958932 Org: User:

Start: 09/30/09 End: 05/31/13 Due: 05/31/14

The Effect of Obesity on Lung Functioning

Phase: N/A Priority: Normal

NCT ID: NCT00284895 Org: User:

Start: 11/30/05 End: 11/30/07 Due: 11/30/08

Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies

Phase: N/A Priority: Normal

NCT ID: NCT00727285 Org: User:

Start: 02/29/08 End: 10/31/12 Due: 10/31/13

The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis

Phase: N/A Priority: Normal

NCT ID: NCT01587001 Org: User:

Start: 11/30/11 End: 10/31/14 Due: 10/31/15

Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels

Phase: N/A Priority: Normal

NCT ID: NCT00851370 Org: User:

Start: 01/31/09 End: 02/28/11 Due: 02/28/12

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis	NCT04397809	National Jewish Health	user2@example.com	None	2014-09-10	2021-08-31	2022-08-31	-	-	2025-07-14
Pneumococcal Post-Vaccination Titers	NCT02726347	National Jewish Health	user2@example.com	None	2016-04-30	2018-04-30	2019-04-30	-	-	2025-07-14
Sub-Sensitivity to Long-Acting Bronchodilators (LABA)	NCT01117116	National Jewish Health	user2@example.com	None	2010-03-31	2013-09-30	2014-09-30	-	-	2025-07-14
Lung Clearance Index to Identify Scleroderma Patients at Risk for ILD	NCT04535245	National Jewish Health	user2@example.com	None	2021-01-04	2026-01-15	2027-01-15	-	-	2025-07-14
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis	NCT02419989	National Jewish Health	user2@example.com	None	2014-01-31	2025-03-31	2026-03-31	-	-	2025-07-14
COPDGene/Lung Cancer Center Database	NCT02445183	National Jewish Health	user2@example.com	None	2013-12-31	2020-09-22	2021-09-22	-	-	2025-07-14
Effects of Sildenafil on CFTR-dependent Ion Transport Activity	NCT01132482	National Jewish Health	user2@example.com	None	2015-10-31	2017-05-31	2018-05-31	-	-	2025-07-14
Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea	NCT03109210	National Jewish Health	user2@example.com	None	2017-04-15	2026-06-30	2027-06-30	-	-	2025-07-14
Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis	NCT03145922	National Jewish Health	user2@example.com	None	2016-01-31	2026-01-31	2027-01-31	-	-	2025-07-14
Phase II Study of Digitoxin to Treat Cystic Fibrosis	NCT00782288	National Jewish Health	user2@example.com	None	2010-08-31	2016-08-31	2017-08-31	-	-	2025-07-14
Utility of Lung Clearance Index Score As a Noninvasive Marker of Small Airways Disease	NCT03241420	National Jewish Health	user2@example.com	None	2017-04-24	2025-12-31	2026-12-31	-	-	2025-07-14
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma	NCT01589198	National Jewish Health	user2@example.com	None	2012-01-31	2016-06-30	2017-06-30	-	-	2025-07-14
The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy	NCT01950533	National Jewish Health	user2@example.com	None	2013-09-30	2017-03-29	2018-03-29	-	-	2025-07-14
Changing School Start Times: Impact on Student, Family, Teacher, and Community Health	NCT03964181	National Jewish Health	user2@example.com	None	2017-04-11	2021-07-31	2022-07-31	-	-	2025-07-14
Dog Hair Extract Study	NCT01343420	National Jewish Health	user2@example.com	None	2010-11-30	2011-10-31	2012-10-31	-	-	2025-07-14
Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis	NCT04024423	National Jewish Health	user2@example.com	None	2019-07-01	2023-07-01	2024-07-01	-	-	2025-07-14
The Role of JAK2 in Alveolar Macrophages (AM's) in Chronic Beryllium Disease (CBD)	NCT02596347	National Jewish Health	user2@example.com	None	2015-04-30	2019-12-06	2020-12-06	-	-	2025-07-14
Deployment-Related Lung Disease Research Database and Biorepository	NCT03035097	National Jewish Health	user2@example.com	None	2013-02-28	2030-12-31	2031-12-31	-	-	2025-07-14
Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma	NCT02753764	National Jewish Health	user2@example.com	None	2017-01-31	2019-02-25	2020-02-25	-	-	2025-07-14
Viral-Related Neutrophil Response and Condition Severity in People With ARDS	NCT00548795	National Jewish Health	user2@example.com	None	2007-08-31	2012-07-31	2013-07-31	-	-	2025-07-14
Telecommunication Enhanced Asthma Management	NCT00958932	National Jewish Health	user2@example.com	None	2009-09-30	2013-05-31	2014-05-31	-	-	2025-07-14
The Effect of Obesity on Lung Functioning	NCT00284895	National Jewish Health	user2@example.com	None	2005-11-30	2007-11-30	2008-11-30	-	-	2025-07-14
Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies	NCT00727285	National Jewish Health	user2@example.com	None	2008-02-29	2012-10-31	2013-10-31	-	-	2025-07-14
The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis	NCT01587001	National Jewish Health	user2@example.com	None	2011-11-30	2014-10-31	2015-10-31	-	-	2025-07-14
Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels	NCT00851370	National Jewish Health	user2@example.com	None	2009-01-31	2011-02-28	2012-02-28	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance